DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
5.63
-0.09 (-1.50%)
May 21, 2026, 11:30 AM EDT - Market open
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $303.58 million as of May 21, 2026. Its market cap has increased by 83.55% in one year.
Market Cap
303.58M
Enterprise Value
257.09M
1-Year Change
83.55%
Ranking
Category
Stock Price
$5.63
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $303.58M, an increase of 727.20%. That is a compound annual growth rate of 32.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 308.20M | -25.65% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 317.03M |
| Surrozen | 315.20M |
| Immuneering | 315.08M |
| Lineage Cell Therapeutics | 309.13M |
| Abeona Therapeutics | 306.06M |
| Bicycle Therapeutics | 303.92M |
| Palisade Bio | 303.04M |
| Nautilus Biotechnology | 299.91M |